Loss of LPS is involved in the virulence and resistance to colistin of colistin-resistant Acinetobacter nosocomialis mutants selected in vitro

Journal of Antimicrobial Chemotherapy

Volumn 70, Issue 11, 2015, Pages 2981-2986

  Vila Farrés, Xavier ^a,b   Ferrer Navarro, Mario ^a   Callarisa, Anna Elena ^a   Martí, Sara ^a   Espinal, Paula ^a   Gupta, Sushim ^c   Rolain, Jean Marc ^c   Giralt, Ernest ^b,d   Vila, Jordi ^a,d  

^a CENTRE FOR RESEARCH IN ENVIRONMENTAL EPIDEMIOLOGY CREAL   (Spain)

^b INSTITUTE FOR RESEARCH IN BIOMEDICINE   (Spain)

^c AIX MARSEILLE UNIVERSITY   (France)

^d UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AZTREONAM; CEFOXITIN; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; ERTAPENEM; ETHIONAMIDE; IMIPENEM; LIPID A; LIPOPOLYSACCHARIDE; TIGECYCLINE; TOBRAMYCIN; VANCOMYCIN; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; PROTEOME; VIRULENCE FACTOR;

ACINETOBACTER; ACINETOBACTER NOSOCOMIALIS; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM MUTANT; CAENORHABDITIS ELEGANS; CELL SURFACE; COMPARATIVE STUDY; DOWN REGULATION; FATTY ACID SYNTHESIS; GENE; GENE MUTATION; GENE SEQUENCE; GENOMICS; IN VITRO STUDY; IN VIVO STUDY; LIPID STORAGE; LIPOGENESIS; LPXD GENE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; STOP CODON; ACINETOBACTER INFECTION; ANIMAL; BACTERIAL GENOME; BIOSYNTHESIS; DISEASE MODEL; DNA MUTATIONAL ANALYSIS; DRUG EFFECTS; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; MUTATION; PATHOGENICITY; VIRULENCE; VIRUS CULTURE;

ACINETOBACTER; ACINETOBACTER INFECTIONS; ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; CAENORHABDITIS ELEGANS; COLISTIN; DISEASE MODELS, ANIMAL; DNA MUTATIONAL ANALYSIS; DRUG RESISTANCE, BACTERIAL; GENOME, BACTERIAL; LIPOPOLYSACCHARIDES; MUTATION; PROTEOME; SERIAL PASSAGE; VIRULENCE; VIRULENCE FACTORS;

EID: 84949035631     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkv244     Document Type: Article

References (25)

1. Roca I, Espinal P, Vila-Farrés X et al. The Acinetobacter baumannii oxymoron: commensal hospital dweller turned pan-drug-resistant menace. Front Microbiol 2012; 3: 148.
2. Teixeira AB, Martins AF, Barin J et al. First report of carbapenem-resistant Acinetobacter nosocomialis isolates harboring ISAba1-blaOXA-23 genes in Latin America. J Clin Microbiol 2013; 51: 2739-41.
3. Zander E, Fernández-González A, Schleicher X et al. Worldwide dissemination of acquired carbapenem-hydrolysing class D ß-lactamases in Acinetobacter spp. other than Acinetobacter baumannii. Int J Antimicrob Agents 2014; 43: 375-7.
4. Zhang R, Hu YY, Yang XF et al. Emergence of NDM-producing nonbaumannii Acinetobacter spp. isolated from China. Eur J Clin Microbiol Infect Dis 2014; 33: 853-60.
5. Ageevets VA, Partina IV, Lisitsyna ES et al. Emergence of carbapenemase-producing Gram-negative bacteria in Saint Petersburg, Russia. Int J Antimicrob Agents 2014; 44: 152-5.
6. Olaitan AO, Morand S, Rolain JM. Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria. Front Microbiol 2014; 5: 643.
7. Adams MD, Nickel GC, Bajaksouzian S et al. Resistance to colistin in Acinetobacter baumannii associated with mutations in the PmrAB two-component system. Antimicrob Agents Chemother 2009; 53: 3628-34.
8. Arroyo LA, Herrera CM, Fernández L et al. The pmrCAB operon mediates polymyxin resistance in Acinetobacter baumannii ATCC 17978 and clinical isolates through phosphoethanolamine modification of lipid A. Antimicrob Agents Chemother 2011; 55: 3743-51.
9. Beceiro A, Llobet E, Aranda J et al. Phosphoethanolamine modification of lipid A in colistin-resistant variants of Acinetobacter baumannii mediated by the pmrAB two-component regulatory system. Antimicrob Agents Chemother 2011; 55: 3370-9.
10. Moffatt JH, Harper M, Harrison P et al. Colistin resistance in Acinetobacter baumannii is mediated by complete loss of lipopolysaccharide production. Antimicrob Agents Chemother 2010; 54: 4971-7.
11. Park YK, Lee JY, Ko KS. Transcriptomic analysis of colistin-susceptible and colistin-resistant isolates identifies genes associated with colistin resistance in Acinetobacter baumannii. Clin Microbiol Infect 2015; 21: 765.e1-7.
12. Lee YC, Huang YT, Tan CK et al. Acinetobacter baumannii and Acinetobacter genospecies 13TU and 3 bacteraemia: comparison of clinical features, prognostic factors and outcomes. J Antimicrob Chemother 2011; 66: 1839-46.
13. Yang YS, Lee YT, Tsai WCet al. Comparison between bacteremia caused by carbapenem resistant Acinetobacter baumannii and Acinetobacter nosocomialis. BMC Infect Dis 2013; 13: 311.
14. Huang L, Chen TL, Lee Yet al. Risk factors for imipenem-non susceptible Acinetobacter nosocomialis bloodstream infection. J Microbiol Immunol and Infect 2014; 47: 311-7.
15. Vaneechoutte M, Dijkshoorn L, Tjernbert I et al. Identification of Acinetobacter genomic species by amplified ribosomal DNA restriction analysis. J Clin Microbiol 1995; 33: 11-5.
16. Lavigne JP, Nicolas-Chanoine MH, Bourg G et al. Virulent synergistic effect between Enterococcus faecalis and Escherichia coli assayed by using the Caenorhabditis elegans model. PLoS One 2008; 3: e3370.
17. Møller AK, Leatham MP, Conway T et al. An Escherichia coli MG1655 lipopolysaccharide deep-rough core mutant grows and survives in mouse cecal mucus but fails to colonize the mouse large intestine. Infect Immun 2003; 71: 2142-52.
18. López-Rojas R, Jiménez-Mejías ME, Lepe JA et al. Acinetobacter baumannii resistant to colistin alters its antibiotic resistance profile: a case report from Spain. J Infect Dis 2011; 204: 1147-8.
19. López-Rojas R, McConnell MJ, Jiménez-Mejías ME et al. Colistin resistance in a clinical Acinetobacter baumannii strain appearing after colistin treatment: effect on virulence and bacterial fitness. Antimicrob Agents Chemother 2013; 57: 4587-9.
20. Beceiro A, Moreno A, Fernández N et al. Biological cost of different mechanisms of colistin resistance and their impact on virulence in Acinetobacter baumannii. Antimicrob Agents Chemother 2014; 58: 518-26.
21. García-Quintanilla M, Pulido MR, Moreno-Martínez P et al. Activity of host antimicrobials against multidrug-resistant Acinetobacter baumannii acquiring colistin resistance through loss of lipopolysaccharide. Antimicrob Agents Chemother 2014; 58: 2972-5.
22. Shivachandra SB, Kumar A, Yogisharadhya R et al. Immunogenicity of highly conserved recombinant VacJ outer membrane lipoprotein of Pasteurella multocida. Vaccine 2014; 32: 290-6.
23. Shen L, Gao X,Wei J et al. PA2800 plays an important role in both antibiotic susceptibility and virulence in Pseudomonas aeruginosa. Curr Microbiol 2012; 65: 601-9.
24. Catel-Ferreira M, Coadou G, Molle V et al. Structure-function relationships of CarO, the carbapenemresistance-associated outer membrane protein of Acinetobacter baumannii. J Antimicrob Chemother 2011; 66: 2053-6.
25. Henry R, Vithanage N, Harrison P et al. Colistin-resistant, lipopolysaccharide-deficient Acinetobacter baumannii responds to lipopolysaccharide loss through increased expression of genes involved in the synthesis and transport of lipoproteins, phospholipids, and poly-ß-1,6-N-acetylglucosamine. Antimicrob Agents Chemother 2012; 56: 59-69.